Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Ewa Krzywdzinska has worked on the following 4 EPO patent applications which have been published in the last five years:

EP11715079

PROCESS FOR PREPARATION OF POLYMORPHIC FORM AND NEW POLYMORPHIC FORM OF IMATINIB MESYLATE ISOLATED IN THAT PROCESS

IPC classification:
C07D 401/04
Agent:
Ewa Krzywdzinska, Pharmaceutical Research Institute (Instytut Farmaceutyczny)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13717581

PROCESS FOR PREPARATION OF PROSTAGLANDIN F2alpha ANALOGUES

IPC classification:
C07C 405/00, C07F 7/18
Applicant:
Pharmaceutical Research Institute (Instytut Farmaceutyczny)
Agent:
Ewa Krzywdzinska, Pharmaceutical Research Institute (Instytut Farmaceutyczny)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13828891

PROCESS FOR PREPARATION OF 3,24;16,22-DI-O,O-ISOPROPYLIDENEPROTOESCIGENIN AND CRYSTALLINE FORMS THEREOF

IPC classification:
C07J 63/00, C07J 71/00
Applicant:
Warsaw Medical University (Warszawski Uniwersytet Medyczny)
Agent:
Ewa Krzywdzinska, Pharmaceutical Research Institute (Instytut Farmaceutyczny)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14732453

PROCESS FOR THE PREPARATION OF HIGH PURITY AMORPHOUS PEMETREXED DISODIUM AND CRYSTALLINE FORMS OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID

IPC classification:
C07D 487/04
Agent:
Ewa Krzywdzinska, Pharmaceutical Research Institute (Instytut Farmaceutyczny)
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature